510(k) K896572
K896572 is an FDA 510(k) premarket notification submitted by Helena Laboratories for the device "REP(TM) SPE PLUS-30 PROCEDURES". The FDA issued a decision of Substantially Equivalent on January 11, 1990. The device falls under product code CFP (Radioimmunoassay, Immunoreactive Insulin), a Class I device regulated under 21 CFR 862.1405. Helena Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 11, 1990
- Date Received
- November 20, 1989
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Immunoreactive Insulin
- Device Class
- Class I
- Regulation Number
- 862.1405
- Review Panel
- CH
- Submission Type